Clinicians and researchers from New York’s Columbia University have reported the delivery of a healthy baby girl following the first use of pre-implantation genetic diagnosis for the screening of at risk embryos for Stargardt’s disease. The newborn’s parents had sought genetic counselling and had been tested resulting in confirmation that the father carried 2 ABCA4 mutations while the mother carried 1 potentially pathogenic ABCA4 mutation.